Browse Studies — Arctuva

Type 1 Diabetes Extension Study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Di…

Type 1 Diabetes MellitusT1DMT1D

Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT02734277

Phase 1

A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Participants Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending d…

Type 1 Diabetes MellitusT1DT1DM+7 more

Estimated

~$10 – $8,750

COUR Pharmaceutical Development Company, Inc.NCT06783309

Phase 1

A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus

This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tole…

Diabetes Mellitus, Type 1HypoglycemiaIslet Cell Transplantation+14 more

Estimated

~$10 – $8,750

Otsuka Pharmaceutical Factory, Inc.NCT06575426

Observational

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

This study aims to improve patient awareness of the utility of continuous glucose monitoring systems in blood glucose monitoring and to improve patient satisfa…

Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes Mellitus (T1DM)Hyperglycemia

Estimated

~$10 – $6,250

Vanderbilt University Medical CenterNCT06852950